Nbryo launches Spring Trial Ambassador Program

priority access and discounted IVF rates for AWA members

Nbryo launches Spring Trial Ambassador Program

Priority access and discounted IVF rates for AWA members

Imagine being able to identify your best genetics, genomically select the traits you’d like, multiply these many times over and then AFFORDABLY transfer these into recipient females. This is the Nbryo vision.

After more than 15 years of R&D, major grant funding and input from universities, companies and research institutions globally, Nbryo’s game-changing technology platform is poised to transform the entire value chain. Research to develop the Nbryo platform has been funded by MLA, the Bill & Melinda Gates Foundation and Nbryo Pty Ltd. Additionally, Nbryo has attracted significant equity investment to further its commercialisation capability.

While in vitro produced embryos and embryo transfer is not new, technology to make it cost effective for commercial herds is a game-changer.

The challenge to date has been that existing assisted breeding technologies are out-dated and difficult to scale. A typical well-run genetic improvement program today, can deliver at best, a 10% change in a trait or an index of traits in a 7-year period.

As the Nbryo platform rolls out, it will be possible for example, to select the top 10% of embryos with the traits that are desired (in the dish/lab), multiply these and discard the other 90%. For Wagyu breeders, this could mean initially selecting for male or female progeny, eliminating animals carrying the horned gene and eliminating any embryos carrying undesirable genetic conditions.  The resulting embryos can then be scaled significantly.

With the ability to condense 7 years of genetic improvement into 7 days and technology being developed to enable semi-skilled operators to transfer embryos into exactly the right place and at the right time, this ambitious vision is on the cusp of being realised.

With the lab operational and live calves on the ground from our existing technology Nbryo is now ‘open for business’.

As part of its Platinum Partnership, Nbryo is offering AWA members discounted rates and priority access to its Spring Trial Ambassador Program* (TAP).  To find out more, click the button below and/or learn more from the Nbryo Webinar being held for AWA members only from 7.30-8.15pm on Monday 5th August.

Learn more

Webinar Registration

*Terms & Conditions apply

Important Notice and Disclaimer


It is very important that you appreciate when viewing the AWA database that the information contained on the AWA database, including but not limited to pedigree, DNA information, Estimated Breeding Values (EBVs) and Index values, is based on data supplied by members and/or third parties.

Whilst every effort is made to ensure the accuracy of the information reported through AWA, AWA officers and employees assume no responsibility for its content, use or interpretation. AWA disclaims all liability (including without limitation, liability in negligence) for all expenses, losses, damages and costs you may incur as a result of the use by you of the data on this AWA database and the information supplied by ABRI and AGBU being inaccurate or incomplete in any way for any reason.

Regarding EBVs and Index values, it is very important to appreciate, and you need to be aware that:

  • EBVs are derived using Wagyu Single Step BREEDPLAN technology developed independently by the Animal Genetics and Breeding Unit (AGBU), using the information contained within the AWA database.
  • AGBU is a joint venture of NSW Department of Primary Industries and the University of New England, which receives funding for this purpose from Meat and Livestock Australia Limited.
  • AWA relies solely on advice provided by AGBU and ABRI in accepting Wagyu Single Step BREEDPLAN software.
  • EBVs published in Wagyu Single Step BREEDPLAN are estimates of genetic potential of individual animals and may not reflect the raw animal phenotype.
  • EBVs can only be directly compared to other EBVs calculated in the same monthly Wagyu Group BREEDPLAN analysis.

Regarding pedigree and DNA testing results submitted to the AWA, it is very important to appreciate, and you need to be aware that:

  • Pedigree and DNA data submitted and supplied to AWA may have errors in it which cannot be detected without further DNA testing.
  • Technology may have advanced since a particular test was undertaken so that previous inaccuracies which were not detectable are now able to be detected by current testing technology.
  • AWA estimates that less than 1% of the pedigree entries, ownership or breeding details in the AWA Herdbook may have errors or which may be misleading. For this reason, users ought to consider if they need to obtain independent testing of the relevant animal (if possible) to ensure that the data is accurate.

Regarding prefectural content, it is very important to appreciate, and you need to be aware that:

  • Prefectural content is based on the estimation of prefectural origin from Japanese breeding records of 201 foundation sires and 168 foundation dams.  As genotype-based parent verification is not used in Japan, and full Japanese registration certificates are not available for all foundation animals, exact prefectural composition for these sires and dams cannot be validated.
  • The calculation of prefectural content for Australian Herdbook animals relies on the accuracy of pedigree records and DNA samples provided by AWA members.
  • The reporting of prefectural content for animals within the AWA Herdbook relies on the calculation provided by ABRI.

If you consider that you do not understand or appreciate the nature and extent of the data provided on this website or the EBVs of a particular animal, then AWA strongly recommends that you seek independent expert advice.